Goldman Sachs Sees 61% Upside in MAKO (MAKO)

May 23, 2012 10:58 AM EDT Send to a Friend
Get Alerts MAKO Hot Sheet
Price: $11.56 +0.26%

Rating Summary:
    4 Buy, 8 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 13 | Down: 24 | New: 24
Trade MAKO Now!
Goldman Sachs lowered its price target on MAKO Surgical (NASDAQ: MAKO) but kept its Buy rating and still sees 61% upside to its new price target of $36 (down from $42).

Comments come after meetings with management and physicians at the Current Concepts in Joint Replacement (CCJR) meeting.

Goldman sees substantial upside and continues to view the company as a attractive fundamental and strategic asset. They also said several of the factors negatively impacting results are likely to prove transient and execution should improve.

The firm adjusted FY12 EPS from ($0.71) to ($0.73), FY13 from $0.01 to ($0.02) and FY14 from $0.42 to $0.43.

For an analyst ratings summary and ratings history on MAKO Surgical click here. For more ratings news on MAKO Surgical click here.

Shares of MAKO Surgical closed at $22.42 yesterday, with a 52 week range of $21.18-$45.15.


Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here



You May Also Be Interested In


Related Categories

Analyst Comments, Analyst EPS Change, Analyst PT Change

Related Entities

Goldman Sachs

Add Your Comment